Welcome to our dedicated page for CareCloud SEC filings (Ticker: CCLD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CareCloud, Inc. filings document operating results, Regulation FD presentation materials, governance actions, and capital-structure disclosures for a healthcare technology and revenue cycle management company. The records cover common stock, preferred-stock dividend and security matters, credit facility events, and formal updates tied to financial performance.
CareCloud’s proxy and current reports also disclose shareholder voting matters, bylaw amendments, board and audit committee composition, Nasdaq compliance items, and cybersecurity incident reporting. These filings frame the company’s Healthcare IT and Medical Practice Management activities alongside risk, governance, and public-company reporting obligations.
CareCloud, Inc. director Anne Busquet reported the vesting and conversion of 7,500 Restricted Stock Units into an equal number of shares of Common Stock on August 8, 2026. The RSUs and resulting shares were acquired under the company’s Amended and Restated Equity Incentive Plan without payment by the reporting person. Following the transaction, Busquet directly held 308,888 shares of common stock and 37,500 Restricted Stock Units.
CareCloud, Inc. director Bill Korn reported the vesting and conversion of 7,500 Restricted Stock Units into an equal number of shares of common stock on August 8, 2026. The RSUs and resulting shares were issued under the company’s Amended and Restated Equity Incentive Plan without payment by Korn. Following this transaction, Korn directly holds 225,383 shares of common stock and 37,500 Restricted Stock Units.
CareCloud, Inc. director Cameron Munter reported the vesting and conversion of 7,500 Restricted Stock Units into 7,500 shares of common stock on August 8, 2026. The equity was acquired under the company’s Amended and Restated Equity Incentive Plan without payment by the reporting person, leaving 216,500 common shares held directly and 37,500 RSUs outstanding.
CareCloud, Inc. director Lawrence Steven Sharnak reported the vesting and conversion of 7,500 restricted stock units into an equal number of shares of common stock on August 8, 2026. The RSUs and resulting shares were issued under the company’s Amended and Restated Equity Incentive Plan without payment by him. Following these transactions, he held 141,500 shares of common stock directly and 37,500 restricted stock units.
CareCloud, Inc. reported Q2 2026 net revenue of $31.9 million, up from $27.4 million a year earlier, driven mainly by Healthcare IT services and contributions from recent acquisitions including Medsphere, RevNu, MAP App and Empower. Six‑month revenue reached $63.2 million versus $55.0 million in 2025.
Operating income declined to $1.9 million in Q2 and $2.9 million year‑to‑date, with net income of $1.1 million for the quarter and $2.0 million for six months. After $2.3 million of preferred dividends, six‑month earnings attributable to common shareholders were a small loss of $0.3 million. Cash increased to $13.4 million, while total liabilities rose to $76.4 million, reflecting a new credit facility with a $40 million term loan and $10 million revolver, of which $39.2 million and $9.0 million were outstanding and used largely to fund a roughly $41.6 million redemption of all Series B Preferred Stock.
The company continued to amortize $107.3 million of intangible assets and carried $31.8 million of goodwill tied to its acquisition strategy. In March 2026 it experienced a cybersecurity incident that briefly disrupted one electronic health record environment and involved exfiltration of patient information; multiple class actions have been consolidated, and management believes cyber insurance will cover most related costs apart from a $100,000 retention.
CareCloud, Inc. reported Q2 2026 revenue of $31.9 million, up from $27.4 million in Q2 2025, marking its ninth consecutive quarter of positive GAAP net income. GAAP net income was $1.1 million versus $2.9 million a year ago, and GAAP EPS was $0.00 versus $0.04. Adjusted EBITDA was $5.9 million compared with $6.5 million. Year-to-date, revenue reached $63.2 million versus $55.0 million, with GAAP net income of $2.0 million versus $4.9 million and adjusted EBITDA of $11.3 million versus $12.1 million.
The company completed the acquisition of Empower Healthcare & Compliance Partners, entering the compliance and audit-defense market for its network of more than 40,000 providers, and fully redeemed all Series B Preferred Stock on May 15, 2026. During the first half, it received $39.7 million in term-loan proceeds and $9.0 million from its line of credit and used $38.2 million to redeem the Series B, contributing to interest expense of $0.8 million versus $0.1 million in the prior-year quarter.
Cash increased to $13.4 million from $3.1 million at December 31, 2025, while total liabilities were $76.4 million and shareholders’ equity $17.4 million. Free cash flow for the first half of 2026 was $8.1 million versus $9.1 million a year earlier. Management reaffirmed full-year 2026 guidance for revenue of $128–$132 million, adjusted EBITDA of $29–$31 million, and GAAP EPS of $0.20–$0.23.
CareCloud, Inc. director Cameron Munter reported equity compensation activity. On July 29, 2026 he received a grant of 25,000 restricted stock units, each representing one share of common stock, vesting in four equal installments through July 29, 2028. On July 31, 2026, 6,250 RSUs vested and converted into 6,250 common shares at no cost to him under CareCloud’s Amended and Restated Equity Incentive Plan, increasing his directly held common stock to 209,000 shares.
CareCloud, Inc. director Bill Korn reported equity compensation activity. On July 29, 2026, he received a grant of 25,000 Restricted Stock Units, vesting in four equal installments on January 29, 2027, July 29, 2027, January 29, 2028 and July 29, 2028. On July 31, 2026, 6,250 RSUs vested and converted into 6,250 shares of common stock under the company’s Amended and Restated Equity Incentive Plan, without payment by him, bringing his directly held common stock to 217,883 shares.
CareCloud, Inc. director Anne Busquet reported equity compensation activity, including a new restricted stock unit grant and the vesting of previously awarded units.
On July 29, 2026 she was granted 25,000 restricted stock units vesting in four equal installments between January 29, 2027 and July 29, 2028. On July 31, 2026 6,250 restricted stock units vested and converted into common stock under the company’s equity incentive plan, bringing her direct holdings to 301,388 shares.
CareCloud, Inc. director Lawrence Steven Sharnak reported equity-award activity. On July 29, 2026 he received a grant of 25,000 Restricted Stock Units, each convertible into one share of common stock, vesting in four equal installments on January 29, 2027, July 29, 2027, January 29, 2028 and July 29, 2028.
On July 31, 2026, 6,250 RSUs vested and converted into 6,250 shares of common stock at a conversion price of 0.0000 per share, issued under the company’s Amended and Restated Equity Incentive Plan without payment by Sharnak. Following these transactions, he directly holds 134,000 shares of CareCloud common stock.